Investment firm offers illness-related biotech portfolios

A newly created investment firm is offering an investment product that allows individuals to select a portfolio of pharmaceutical and biotech companies working on treatments to fill major illnesses. WellSpring BioCapital Partners, based in Philadelphia, has identified Alzheimer's disease, breast and ovarian cancer, diabetes, prostate cancer and rheumatoid arthritis as the bases of the portfolios it will offer, with each ailment portfolio identifying companies working on treatments.

View Full Article in:

Journal and Constitution (Atlanta) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC